[The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis - possible applications of anti-RANKL antibody to the treatment of cancer patients].
Yasuda, Hisataka
[The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis - possible applications of anti-RANKL antibody to the treatment of cancer patients]. [electronic resource] - Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 11-15 p. digital
Publication Type: Journal Article; Review
0015-5691
10.1254/fpj.153.11 doi
Antibodies, Monoclonal, Humanized
Bone Resorption
Denosumab--pharmacology
Humans
Osteoclasts--cytology
Osteoporosis--therapy
RANK Ligand--immunology
[The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis - possible applications of anti-RANKL antibody to the treatment of cancer patients]. [electronic resource] - Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 11-15 p. digital
Publication Type: Journal Article; Review
0015-5691
10.1254/fpj.153.11 doi
Antibodies, Monoclonal, Humanized
Bone Resorption
Denosumab--pharmacology
Humans
Osteoclasts--cytology
Osteoporosis--therapy
RANK Ligand--immunology